Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies

57Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Glucocorticoids are fundamental drugs used in the treatment of lymphoid malignancies with apoptotic cell death as the hitherto proposed mechanism of action. We have recently shown that dexamethasone induces autophagy in lymphoid leukemia cells and in this particular setting this cell death modality is a prerequisite for the efficient killing of the leukemic cells by dexamethasone. 1 Hence, inhibition of autophagy by siRNA-mediated silencing of Beclin 1, as well as chemical inhibition of type III PtdIns3K, inhibits apoptosis, demonstrating an important role of autophagy in dexamethasone-induced cell death. In this brief report, we review these findings and introduce the multiple myeloma cells as a novel system to study autophagy in response to dexamethasone. © 2009 Landes Bioscience.

Cite

CITATION STYLE

APA

Grandér, D., Kharaziha, P., Laane, E., Pokrovskaja, K., & Panaretakis, T. (2009). Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies. Autophagy, 5(8), 1198–1200. https://doi.org/10.4161/auto.5.8.10122

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free